首页|沉默信息调节因子2在胆管癌中的表达及其对可切除胆管癌患者预后的预测价值

沉默信息调节因子2在胆管癌中的表达及其对可切除胆管癌患者预后的预测价值

扫码查看
目的:探究沉默信息调节因子2(SIRT2)在胆管癌组织中的表达、潜在作用机制及临床意义,并构建可切除胆管癌患者生存预测模型。方法:首先,通过癌症基因图谱和基因表达综合数据库分析SIRT2在胆管癌组织与正常组织中的表达差异,并通过基因集富集分析(GSEA)探讨SIRT2在胆管癌中的潜在机制;其次,免疫组织化学染色检测研究者队列胆管癌组织中SIRT2的表达,并分析SIRT2表达与胆管癌患者临床病理特征和预后的关系。最后,基于COX回归分析结果构建胆管癌术后患者预后列线图预测模型,使用校准曲线及时间依赖性的受试者工作特征曲线(ROC)对列线图模型进行评价,并与美国癌症联合委员会(AJCC)第八版TNM分期预测效果进行比较。结果:公共数据库中SIRT2 mRNA在胆管癌组织中显著过表达,免疫组织化学染色发现SIRT2蛋白在胆管癌组织中表达高于癌旁组织(均P<0。05)。GSEA结果显示,SIRT2高表达可能影响了多种代谢相关信号通路,如脂肪酸代谢、氧化磷酸化、氨基酸代谢等。SIRT2表达与血清三酰甘油水平、肿瘤大小、淋巴结是否转移相关(均P<0。05)。生存分析结果显示,SIRT2高表达患者较低表达患者总生存期显著缩短(P<0。05)。单因素回归分析结果显示,肿瘤分化程度、TNM分期、是否接受后续治疗、SIRT2表达与胆管癌患者预后相关(均P<0。05);多因素回归分析结果进一步证实,TNM分期和SIRT2表达是胆管癌患者总生存期的独立预测因素(均P<0。05)。基于SIRT2构建的胆管癌术后患者列线图生存预测模型C指数为0。675,第1、2、3年的时间依赖性ROC曲线下面积分别为0。879、0。778、0。953,与AJCC第八版TNM分期系统相比具有更好的预后预测价值。结论:可切除胆管癌患者肿瘤组织中SIRT2高表达并与患者不良预后相关,基于SIRT2构建的胆管癌术后患者的预后列线图模型可能比TNM分期系统具有更好的预测作用。
Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on silence information regulator 2 expression
Objective:To develop a prediction model for postoperative prognosis in patients with cholangiocarcinoma(CCA)based on the expression of silence information regulator 2(SIRT2).Methods:The differential expression of SIRT2 between CCA and normal tissues was analyzed using TCGA and GEO databases.Gene set enrichment analysis(GSEA)was used to explore potential mechanisms of SIRT2 in CCA.The expression of SIRT2 protein in CCA tissues and normal tissues(including 44 pairs of specimens)was also detected by immunohistochemistry(IHC)in 89 resectable CCA patients who underwent surgical treatment in the First Affiliated Hospital of Bengbu Medical College between January 2016 and December 2021.The relationship between SIRT2 expression and clinicopathological characteristics and prognosis of CCA patients was analyzed.A survival prediction model for patients with resectable CCA was constructed with COX regression results,the calibration curve and the time-dependent receiver operating characteristic curve(ROC)were used to evaluate the performance of the constructed model,and the predictive power between this model and the American Joint Committee on Cancer(AJCC)/TNM staging system(8th edition)was compared.Results:SIRT2 mRNA was overexpressed in CCA tissues as shown in TCGA and GEO databases.IHC staining showed that SIRT2 protein expression in CCA tissues was significantly higher than that in adjacent non-tumor tissues.GSEA results showed that elevated SIRT2 expression may be involved in multiple metabolism-related signaling pathway,such as fatty acid metabolism,oxidative phosphorylation and amino acid metabolism.SIRT2 expression was related to serum triglycerides level,tumor size and lymph node metastasis(all P<0.05).The survival analysis results showed that patients with higher SIRT2 expression had a significantly lower overall survival(OS)than patients with lower SIRT2 expression(P<0.05).Univariate COX regression analysis suggested that pathological differentiation,clinical stage,postoperative treatment and SIRT2 expression level were associated with the prognosis of CCA patients(all P<0.05).Multivariate regression analysis confirmed that clinical stage and SIRT2 expression level were independent predictors of OS in postoperative CCA patients(both P<0.05).A nomogram based on SIRT2 for prediction of survival in postoperative CCA patients was constructed.The C-index of the model was 0.675,and the area under the time-dependent ROC curve(AUC)for predicting survival in the first,second,and third years was 0.879,0.778,and 0.953,respectively,which were superior to those of AJCC/TNM staging system(8th Edition).Conclusions:SIRT2 is highly expressed in CCA tissues,which is associated with poor prognosis in patients with resectable CCA.The nomogram developed based on SIRT2 may have better predictive power than the AJCC/TNM staging system(8th edition)in prediction of survival of postoperative CCA patients.

CholangiocarcinomaSilence information regulator 2Clinical significancePrognostic modelBioinformatics analysis

王威、季文斌、吕振宇、孙万亮、邵玉、刘静、杨燕

展开 >

蚌埠医学院第一附属医院肿瘤内科,安徽 蚌埠 233004

蚌埠医学院附属蚌埠市第三人民医院

蚌埠医学院第一附属医院肝胆外科,安徽 蚌埠 233004

蚌埠医学院第一附属医院国家药物临床试验机构,安徽 蚌埠 233004

展开 >

胆管癌 沉默信息调节因子2 临床意义 预后模型 生物信息学分析

安徽省教育厅高校自然科学研究重大项目安徽省高校优秀青年人才支持计划蚌埠医学院"512人才培育计划"

2023AH040291gxyq2022042by51202208

2024

浙江大学学报(医学版)
浙江大学

浙江大学学报(医学版)

CSTPCD北大核心
影响因子:0.926
ISSN:1008-9292
年,卷(期):2024.53(1)
  • 17